Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • ATVB Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Cover Art Award
    • ATVB Early Career Award
    • ATVB in Focus
    • Recent Brief Reviews of ATVB
    • Lecture Series
    • Collections
    • Recent Highlights of ATVB
    • Commentaries
    • Browse Abstracts
    • Insight into ATVB Authors
  • Resources
    • Instructions for Authors
    • Online Submission/Peer Review Site
    • Council on ATVB
    • Permissions and Rights Q&A
    • AHA Guidelines and Statements
    • Customer Service and Ordering Information
    • Author Reprints
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • LinkedIn
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Arteriosclerosis, Thrombosis, and Vascular Biology

  • My alerts
  • Sign In
  • Join

  • Facebook
  • LinkedIn
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • ATVB Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Cover Art Award
    • ATVB Early Career Award
    • ATVB in Focus
    • Recent Brief Reviews of ATVB
    • Lecture Series
    • Collections
    • Recent Highlights of ATVB
    • Commentaries
    • Browse Abstracts
    • Insight into ATVB Authors
  • Resources
    • Instructions for Authors
    • Online Submission/Peer Review Site
    • Council on ATVB
    • Permissions and Rights Q&A
    • AHA Guidelines and Statements
    • Customer Service and Ordering Information
    • Author Reprints
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Integrative Physiology/Experimental Medicine

Genetic Ablation of Adamts13 Gene Dramatically Accelerates the Formation of Early Atherosclerosis in a Murine Model

Sheng-Yu Jin, Junichiro Tohyama, Robert C. Bauer, Na Nora Cao, Daniel J. Rader, X. Long Zheng
Download PDF
https://doi.org/10.1161/ATVBAHA.112.247262
Arteriosclerosis, Thrombosis, and Vascular Biology. 2012;32:1817-1823
Originally published July 18, 2012
Sheng-Yu Jin
From the Department of Pathology and Laboratory Medicine, The Children’s Hospital of Philadelphia, Philadelphia, PA (S.-Y.J., N.N.C., X.L.Z.); Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA (J.T., R.C.B., D.J.R.); and Department of Pathology and Laboratory Medicine, and Medicine, The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA (D.J.R., X.L.Z.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Junichiro Tohyama
From the Department of Pathology and Laboratory Medicine, The Children’s Hospital of Philadelphia, Philadelphia, PA (S.-Y.J., N.N.C., X.L.Z.); Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA (J.T., R.C.B., D.J.R.); and Department of Pathology and Laboratory Medicine, and Medicine, The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA (D.J.R., X.L.Z.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert C. Bauer
From the Department of Pathology and Laboratory Medicine, The Children’s Hospital of Philadelphia, Philadelphia, PA (S.-Y.J., N.N.C., X.L.Z.); Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA (J.T., R.C.B., D.J.R.); and Department of Pathology and Laboratory Medicine, and Medicine, The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA (D.J.R., X.L.Z.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Na Nora Cao
From the Department of Pathology and Laboratory Medicine, The Children’s Hospital of Philadelphia, Philadelphia, PA (S.-Y.J., N.N.C., X.L.Z.); Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA (J.T., R.C.B., D.J.R.); and Department of Pathology and Laboratory Medicine, and Medicine, The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA (D.J.R., X.L.Z.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel J. Rader
From the Department of Pathology and Laboratory Medicine, The Children’s Hospital of Philadelphia, Philadelphia, PA (S.-Y.J., N.N.C., X.L.Z.); Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA (J.T., R.C.B., D.J.R.); and Department of Pathology and Laboratory Medicine, and Medicine, The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA (D.J.R., X.L.Z.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
X. Long Zheng
From the Department of Pathology and Laboratory Medicine, The Children’s Hospital of Philadelphia, Philadelphia, PA (S.-Y.J., N.N.C., X.L.Z.); Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA (J.T., R.C.B., D.J.R.); and Department of Pathology and Laboratory Medicine, and Medicine, The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA (D.J.R., X.L.Z.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics
  • eLetters

Jump to

  • Article
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • Sources of Funding
    • Disclosures
    • Footnotes
    • References
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics
  • eLetters
Loading

Abstract

Objective—ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats-13) cleaves von Willebrand factor, thereby modulating thrombosis and inflammation. Low plasma ADAMTS13 activity is associated with cardiovascular events, including myocardial and cerebral infarction. Here, we investigated the role of ADAMTS13 in the development of early atherosclerosis in a murine model.

Methods and Results—Apolipoprotein E–null (ApoE−/−) and Adamts13-null (Adamts13−/−) ApoE−/− mice were fed with a high-fat Western diet for 12 weeks. Atherosclerotic lesions in the aorta and aortic roots were quantified after staining. Leukocyte rolling and adhesion onto cremaster venules after oxidative injury were determined by intravital microscopy. Although plasma cholesterol levels were largely similar in both groups, the extent of atherosclerotic lesions in the aorta en face and in the aortic roots in the Adamts13−/−ApoE−/− mice increased ≈5.5-fold (P=0.0017) and ≈6.1-fold (P=0.0037), respectively. In addition, the ratio of plasma high- to low-molecular-weight von Willebrand factor multimers increased ≈3-fold. The leukocyte rolling velocities were significantly reduced (P<0.001), with an increased number of leukocyte rolling (P=0.0026) and macrophage infiltration into the atherosclerotic lesions in the Adamts13−/−ApoE−/− mice.

Conclusion—Our results suggest that ADAMTS13 plays a critical role in modulating the development of early atherosclerosis, likely through the proteolytic cleavage of ultra-large von Willebrand factor multimers, thereby inhibiting platelet deposition and inflammation.

  • von Willebrand factor–cleaving protease
  • inflammation
  • animal model

Introduction

ADAMTS13, a member of a disintegrin and metalloprotease with thrombospondin type 1 repeats family, is primarily synthesized in the liver.1,2 Plasma ADAMTS13 metalloprotease cleaves a blood adhesion protein, von Willebrand factor (VWF), at the Tyr1605–Met1606 bond.3,4 VWF is synthesized in all vascular endothelial beds and constitutively secreted or stored in Weibel–Palade bodies of the endothelium.5 Upon stimulation by a variety of agonists such as epinephrine,6 ADP,7 and thrombin8 or desmopressin,9 the stored VWF multimers are released. The newly released ultra-large (UL) VWF forms string-like polymers, which remain anchored on the endothelial cell membrane. The cell-bound VWF polymers are highly sensitive to proteolysis by plasma ADAMTS13 metalloprotease.10–12 After being released into circulation, VWF polymers alter their conformations, becoming resistant to ADAMTS13 until they are unfolded by arterial shear stress.13,14 If this process is compromised, UL VWF polymers bind circulating platelets spontaneously and cause exaggerated platelet aggregation and disseminated thromboses in small arteries and capillaries, exemplified by thrombotic thrombocytopenic purpura, a potentially fatal syndrome.14–16

ADAMTS13 and VWF play an opposite role in thrombosis and systemic inflammation. Adamts13-null (Adamts13−/−) mice exhibit an increase in leukocyte rolling, adhesion, and extravasation in a murine model of acute inflammation.17 Epidemiological studies also show an association between the reduced ratio of plasma ADAMTS13 activity to VWF antigen and pathological conditions such as chronic inflammation18 and cardiovascular19 or cerebrovascular events.20

Here, we demonstrate that genetic ablation of the Adamts13 gene in the Apolipoprotein E–null mice (Adamts13−/−ApoE−/−) fed a high-fat Western diet dramatically accelerates the development of early atherosclerosis. Also, an increased leukocyte rolling over endothelium after oxidative injury and increased macrophage infiltration into atherosclerotic lesions may underlie the pathogenesis of atherosclerosis in Adamts13−/−ApoE−/− mice. Together, our findings demonstrate the critical role of ADAMTS13 proteolysis in modulating early atherosclerosis in genetically susceptible mice.

Methods

Animals and Diet

All animal studies were approved by the Institutional Animal Care and Use Committees at The Children’s Hospital of Philadelphia and The University of Pennsylvania Perelman School of Medicine. ApoE−/− mice (C57BL/6J strain) were purchased from the Jackson Laboratory (Bar Harbor, ME). Adamts13−/− mice (C57BL/6/129 strain) were kindly provided by Dr David Ginsburg (Department of Internal Medicine, University of Michigan, Ann Arbor, MI). ApoE−/− and Adamts13−/− mice were bred for >4× to generate Adamts13−/−ApoE−/− mice. Mice at the age of 6 weeks were fed with a high-fat Western diet from Harlan Laboratories (Madison, WI), consisting of 21.2% fat and 0.2% cholesterol for a total of 12 weeks.

Blood Collection

Whole blood (200 µL) was collected via retro-orbital sinus plexus from mice after 4 hours of fasting for plasma lipid analyses. The blood was anticoagulated (9:1, vol:vol) with 3.9% sodium citrate. Plasma was obtained after centrifugation for 10 minutes at 10 000 rpm in a microcentrifuge and stored in aliquots at −80°C.

En Face Oil Red Staining of Atherosclerotic Lesions in Aorta

Mice were euthanized by intraperitoneal injection of a lethal dose of Nembutal. The entire aorta and heart were surgically isolated under a dissecting microscope and fixed overnight with 10% neutral buffered formalin. The extent of atherosclerotic lesions en face in the aorta was determined by Oil Red O staining.21 All images were obtained under a light microscope with magnifications (×100 and ×200) and quantified by NIH ImageJ analysis software.

Histological Examination of Atherosclerotic Lesions in Aortic Roots

The heart was fixed overnight with 10% neutral buffered formalin and embedded with tissue freezing medium (Ted Pella Inc, Redding, CA). The heart was then sectioned (6 µm, interspaced by 80 µm) using a cryostat. Twelve tissue sections from each heart were placed on each slide and stained with hematoxylin and eosin in the histology core facility at the University of Pennsylvania. Digital images were obtained for each section using a Nikon ECLIPSE-80i microscope equipped with a Nikon digital camera DXM1200 (Nikon Inc, Melville, NY). The areas of atherosclerotic lesions in all sections of entire aortic roots were analyzed with ImageJ software in a blinded fashion.

Plasma VWF Multimer Analysis

Citrated mouse plasma (1.0 μL) was denatured by heating at 60°C for 20 minutes in 70 mmol/L Tris-HCl, pH 6.5 containing 2.4% sodium dodecyl sulfate, 4% urea, and 4 mmol/L EDTA. The denatured sample was fractionated on a 1.0% SeaKem HGT agarose (Cambrex, East Rutherford, NJ) mini-gel by electrophoresis at 15 mA for 2.5 hours. After being transferred onto a nitrocellulose membrane (Bio-Rad, Hercules, CA), the membrane was blocked by tris-buffered saline with casein (20 mmol/L Tris-HCl, pH 7.5, 150 mmol/L NaCl, and 1% casein) for 30 minutes. The membrane was incubated overnight at 4°C with rabbit anti-VWF IgG (DAKO, Carpinteria, CA) in tris-buffered saline with casein (1:1500), followed by an incubation with IRDyeCW800-labeled goat anti-rabbit IgG (LI-COR, Lincoln, NE) in tris-buffered saline with casein (1:12 500) for 1 hour. The fluorescent signal was obtained using an Odyssey imaging system (LI-COR).

Lipid Analysis

Plasma total cholesterol, high-density lipoprotein (HDL) cholesterol, and triglyceride levels were determined on a chemistry analyzer (Roche Diagnostics Systems, Indianapolis, IN) using commercially available reagents (Wako Pure Chemical Industries and Trinity Biotech, Jamestown, NY).

Leukocyte Rolling and Velocity Rate

Mice were anesthetized with an intraperitoneal injection of Nembutal. Cremaster vessels were exposed and injured by topical application of a filter paper soaked with 2.5% FeCl3 for 10 seconds. Rhodamine 6G (Sigma, St. Louis, MO) (1 µg/g body weight diluted with 100 µL of PBS) was injected via retro-orbital sinus plexus to label leukocytes and platelets. The leukocytes rolling over the injured vessels were recorded in real time under an inverted fluorescent microscope (×100) equipped with a high-speed digital camera (Olympics, Center Valley, PA). All movies were recorded using the NIS Elements software from Nikon Instruments, Inc (Melville, NY) (Movies I and II in the online-only Data Supplement).

The number of leukocyte rolling and rolling velocity (µm/second) were determined offline using the NIS Elements image analysis program. The number of leukocytes rolling over the injured vessel was determined at 6 different sites in each mouse for a total of 6 mice in each group. The velocity was determined by Equation (1):

Formula(1)

Here, v refers to the velocity (μm/second).

The cumulative frequencies as a function of various velocities were fit into a sigmoidal curve using the GraphPad software (La Jolla, CA).

Immunohistochemical Staining of Macrophages

After being embedded into tissue freezing medium, formalin-fixed aortic tissues were sectioned (6 µm) using a cryostat. Tissue sections were rinsed with PBS and treated with 0.1 mol/L sodium citrate (pH 6.0) for 5 minutes in a pressure cooker to retrieve antigen. After being blocked with avidin–biotin blocking solution (Vector, Burlingame, CA), the tissue sections were incubated overnight at 4°C with rat anti-mouse CD107b (Mac3) (BD Pargmingen, San Jose, CA) (1:100), followed by incubation for 1 hour with ImmPRESS anti-rat IgG (vector) (Vector Laboratories, Burlingame, CA). The tissue sections were counterstained with hematoxylin and mounted with Permount medium purchased from Fisher Scientific (Pittsburgh, PA). Digital images were obtained under a Nikon Eclipse 80i fluorescent microscope.

Statistical Analysis

The means and SD or SEM were determined. The difference of the continuous variances between 2 groups was determined by the 2-tailed Student t test. One-way ANOVA with Prism5 GraphPad Software determined the significant differences among various groups.

Results

Adamts13−/−ApoE−/− Mice Show an Increased Formation of Atherosclerotic Lesions in Aorta and Aortic Roots

Epidemiological studies suggest that a reduced ratio of plasma ADAMTS13 activity to plasma VWF antigen is a risk factor for the development of cardiovascular diseases, particularly myocardial infarction19,22,23 and ischemic stroke.20,24 However, the causative role of the reduced plasma ADAMTS13 activity and elevated plasma VWF has not been fully established. To address this question, Adamts13−/−ApoE−/− and ApoE−/− mice at the age of 6 weeks were fed a high-fat Western diet for 12 weeks and then euthanized. The entire aorta was isolated, fixed, and stained en face with Oil Red O. The results showed substantially greater lesion development in Adamts13−/−ApoE−/− mice (Figure 1B) compared with that in ApoE−/− mice (Figure 1A). Histological examination after hematoxylin and eosin staining confirmed the atherosclerotic lesion in both groups of mice (Figure 1C and 1D). Image analyses demonstrated that the relative surface areas of atherosclerotic plaques in the aortas of the Adamts13−/−ApoE−/− mice increased ≈5.5-fold (P=0.00165) (Figure 1E). Furthermore, the hearts were harvested, embedded, and cryosectioned. The heart sections were stained with hematoxylin and eosin, revealing substantially greater lesion development in the Adamts13−/−ApoE−/− mice (Figure 2B) than in the ApoE−/− mice (Figure 2A). Image analyses further showed that the extent of atherosclerotic lesions in the aortic roots in the Adamts13−/−ApoE−/− mice increased ≈6.1-fold (Figure 2C) (P=0.00367). These results demonstrate that ADAMTS13 metalloprotease may play a critical role in protecting against the formation of early atherosclerosis in genetically susceptible mice.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Atherosclerotic lesions in the entire aorta. ApoE−/− (A and C) or Adamts13−/− ApoE−/− (B and D) mice at the age of 4 weeks were fed with a Western high-fat diet for 12 weeks. The mice (n=13, in each group) were euthanized, and the entire aorta was isolated, fixed, and stained with Oil Red (A and B). In addition, the aorta were sectioned after paraffin embedding and stained with hematoxylin and eosin (C and D) (×200 and ×400). Digital images were obtained under a light microscope with magnifications of ×100 (A and B) or ×200 (A-a and B-b). E, The relative area of atherosclerotic plaques to the entire aorta with en face method was quantified with ImageJ software. Long and short lines across the dots in both groups represent the means and SD, respectively. Student t test was used to determine the significance between the 2 groups. A P value <0.01 is considered to be statistically highly significant. Arrows indicate the areas of atherosclerotic lesions.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Histological examination of atherosclerotic lesions in the aortic roots. ApoE−/− (A) and Adamts13−/−ApoE−/− (B) mice were euthanized after 12 weeks on a high-fat Western diet. Hearts were fixed with 10% neutral buffered formalin and embedded into tissue freezing medium. A series of sections (6 µm each, spaced by 80 µm) across the aortic roots were prepared using cryostat and stained with hematoxylin and eosin. Images were obtained under light microscope at ×200. ImageJ software was used to quantify the areas of atherosclerotic lesions in all sections (arrowheads indicated). The long and short lines represent the means and SD (n=6 mice, in each group) (C). Student t test was used to determine the significance of the difference between the 2 groups. A P value <0.01 is considered to be statistically highly significant.

UL VWF Multimers Are Present in Adamts13−/−ApoE−/− Mice

Mice deficient for plasma ADAMTS13 activity show an accumulation of UL VWF multimers on stimulated or damaged endothelial cells25 and in plasma.26,27 To determine whether ApoE deficiency plus being fed with a Western diet further impair VWF homeostasis, we determined plasma VWF multimer distribution by agarose gel electrophoresis as described in the Methods section. The ratio of UL VWF to low-molecular-weight VWF multimers in the Adamts13−/−ApoE−/− increased by ≈3-fold compared with that in the ApoE−/− or wild-type mice (Figure 3A and 3B). However, the ratio of UL VWF to low-molecular-weight VWF in these mice was not significantly different from that in the Adamts13−/− mice (Figure 3). These results demonstrate that genetic ablation of Adamts13 gene results in an accumulation of UL VWF multimers in plasma, but the additional deletion of the ApoE plus a high-fat diet has no further deleterious effect on VWF homeostasis.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Plasma von Willebrand factor (VWF) multimer distribution in various mice. A, Plasma VWF multimers from wild-type (WT), ApoE−/−, A13−/−ApoE−/−, and A13−/− mice were determined using agarose (1%) gel electrophoresis and Western blotting as described in the Methods section. B, ImageJ software was used to determine the ratio of ultra-large (UL) to low-molecular-weight (LMW) VWF multimers as indicated in the right side of the image in A from various groups of mice (n=5 in each group). P values <0.05 and <0.01 are considered to be statistically significant and highly significant, respectively. A13−/− indicates Adamts13−/−.

Adamts13 Deficiency Has Little Effect on Plasma Cholesterol Metabolism

To rule out the potential effect of Adamts13 proteolysis on cholesterol metabolism, we determined plasma total cholesterol, HDLs, and triglycerides in various groups of mice after being fed a high-fat Western diet for 12 weeks. The levels of total cholesterol, non-HDL cholesterol, and triglycerides did not significantly differ between Adamts13−/−ApoE−/− mice and ApoE−/− mice, whereas the levels of HDL cholesterol in Adamts13−/−ApoE−/− mice (95.3±39.0 mg/dL) were slightly higher than in ApoE−/− mice (65.6±17.4 mg/dL). The difference was statistically highly significant (P=0.02) (Table). The similar lipid profiles in both groups except for an increased level of HDL cholesterol in Adamts13−/−ApoE−/− mice suggest that the increase in atherosclerotic plagues is not the result of impaired cholesterol metabolism, but the direct effect of lacking ADAMTS13 metalloprotease.

View this table:
  • View inline
  • View popup
Table 1.

Plasma Levels of Total Cholesterol, HDL, Triglyceride, and Non-HDL in ApoE−/− and Adamts13−/−ApoE−/− Mice

Increased Leukocyte Rolling, Adhesion, and Infiltration in the Adamts13−/−ApoE−/− mice

VWF is the only known substrate of ADAMTS13 identified to date. Previous studies show that Adamts13−/− mice have enhanced systemic inflammatory responses, exhibiting increased leukocyte rolling, adhesion, and extravasation, which depend on VWF.17 By intravital microscopy, we showed that the number of fluorescent rhodamine 6G–labeled leukocytes rolling over or adhered to the injured venules was significantly increased in Adamts13−/−ApoE−/− mice (44.1±1.5, means±SEM, n=6) compared with that in ApoE−/− mice (24.7±0.8, means±SEM, n=6) (P=0.0026) (Figure 4). Consistently, the velocity of leukocyte rolling in the same vessels in the Adamts13−/−ApoE−/− mice was dramatically reduced (P<0.001) (Figure 4). These findings were mirrored by the increased number of infiltrated macrophages (Mac-3 positive) in the atherosclerotic plagues in the Adamts13−/−ApoE−/− mice (Figure 5). Together, these results indicate that ADAMTS13 metalloprotease plays an important role in attenuating systemic inflammatory responses.

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Leukocyte rolling and adhesion on cremaster venules after oxidative injury. Cremaster venules of ApoE−/− and Adamts13−/−ApoE−/− mice were exposed after being anesthetized. The venules were injured by topical application of a filter paper soaked with 2.5% of FeCl3. Fluorescein-labeled leukocytes rolling over the injured vessel walls were imaged in real time under an inverted fluorescent microscope. Snap shots of adhered leukocytes in ApoE−/− (A) and Adamts13−/−ApoE−/− mice (B) are shown. The numbers of leukocytes rolling over the injured vessel wall per minute (cells/min) (C) and the cumulated frequencies of leukocyte rolling at various velocities (µm/second) (D) were determined using the NIS Elements software. The data shown in C are the means and SE from 6 mice in each group (5 different sites in each mouse). Statistical analysis was performed by the Student t test (C) and one-way ANOVA (D), respectively. P values <0.01 are considered to be statistically highly significant.

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Immunoperoxidase staining for macrophages in aortic arch sections. Aortic arch sections from the hearts of ApoE−/− mice (A and B) and the Adamts13−/−ApoE−/− mice (C and D) were stained with rat anti-mouse Mac-3 IgG, followed by biotin-labeled anti-rat IgG and ABC reagents as described in the Methods section. Digital images were obtained under a light microscope with magnification of ×400 (A and C) and ×1000 (B and D). Brown staining (arrowheads) indicates Mac-3–positive macrophages.

Discussion

In the present study, we demonstrate that Adamts13−/−ApoE−/− mice develop more extensive and larger atherosclerotic plaques in the branch points of the aorta (Figure 1) and the aortic roots (Figure 2) after 12 weeks on a high-fat Western diet. These results suggest that ADAMTS13 metalloprotease protects against the development of early atherosclerosis in a genetically susceptible animal. Interestingly, the increase in atherosclerotic lesions in both the aorta and aortic arches in the Adamts13−/−ApoE−/− mice appears to be much greater than that recently reported.28 This discrepancy is not simply caused by the relatively low volume of atherosclerotic lesions in our control mice, because the area of atherosclerotic lesions in ApoE−/− mice (Figures 1 and 2) from both studies is comparable.28 Although total cholesterols, triglycerides, and LDLs are not significantly altered, plasma HDL levels are significantly increased in Adamts13−/−ApoE−/− mice in this study (P=0.02). The mechanism underlying the HDL elevation in Adamts13−/−ApoE−/− mice is yet to be determined.

It is also not clear how ADAMTS13 metalloprotease protects against the formation of early atherosclerosis in ApoE−/− mice. We hypothesize that the deficiency of plasma ADAMTS13 activity results in an accumulation of UL VWF multimers on endothelial cell surfaces and in plasma, which enhances both platelet aggregation and systemic inflammation. This hypothesis is based on a number of published studies showing the accumulation of UL VWF strings on endothelial cells upon injury in Adamts13−/− mice.17,25,29 An infusion of recombinant ADAMTS13 rapidly eliminates the cell-bound VWF strings in vivo.25,29 We showed that the ratio of plasma UL VWF to low-molecular-weight VWF multimers in either Adamts13−/− mice26 or Adamts13−/−ApoE−/− mice was dramatically increased (Figure 3). Both UL VWF multimers and adherent platelets have been shown to promote systemic and local inflammation and play a role in the development of atherosclerosis.30,31 Consistent with this notion, the number of leukocytes rolled over the injured vessels increases ≈2-fold, corresponding with the significant reduction in leukocyte rolling velocity (Figure 4), which results in increased macrophage infiltration into the atherosclerotic lesions (Figure 5). Similar findings have recently been reported at the site of atherosclerotic plagues in the carotid artery.32 Together, these data suggest that an increased inflammatory response in Adamts13−/−ApoE−/− mice may contribute to the accelerated formation of atherosclerosis.

It remains to be determined, however, whether ADAMTS13 has a direct effect and/or an indirect effect through reducing the adhesiveness of ULVWF to inhibit atherosclerosis. A previous study demonstrated an ≈40% reduction of atherosclerotic lesion area in the vwf−/−and LDLR−/− mice compared with the LDLR−/− mice after 8 weeks on a high-fat diet.31 Furthermore, an inhibition of platelet adhesion to VWF with a monoclonal antibody against glycoprotein 1bα also reduced leukocyte adhesion and formation of atherosclerotic lesions in the ApoE−/− mice.30 These results support that VWF, platelets, and leukocytes all play a role in the development of early atherosclerosis.

The interaction between VWF and leukocytes is largely mediated by binding of endothelial VWF to leukocyte P-selectin glycoprotein ligand-1,32,33 P-selectin, and L-selectin.34,35 P-selectin glycoprotein ligand-1−/− mice exhibit selective impairment in leukocyte recruitment into the atherosclerotic arterial wall.36 Inhibition of P-selectin completely abrogates leukocyte rolling in Adamts13−/− mice, suggesting that P-selectin is required for initiating leukocyte rolling even in the presence of endothelial VWF strings.17

In conclusion, we demonstrate that the genetic ablation of Adamts13 gene in ApoE-null mice fed a high-fat diet results in an accelerated formation of early atherosclerosis. We hypothesize that the underlying mechanism may be associated with increased systemic and local inflammation as reflected by increased initial leukocyte rolling, adhesion, and infiltration at the site of injury. Our findings provide further evidence demonstrating the critical role of ADAMTS13 metalloprotease in attenuating the formation of early atherosclerotic plagues in a genetically susceptible individual.

Acknowledgments

We thank Dr David Ginsburg from the Department of Genetics, University of Michigan, Ann Arbor, for providing Adamts13−/− mice.

Sources of Funding

This study is partially supported by grants from the American Heart Association Established Investigator Award (AHA-0940100N) and National Institutes of Health (P01HL074124, project 3).

Disclosures

None.

Footnotes

  • ↵*These authors contributed equally to this work.

  • The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/doi:10.1161/ATVBAHA.112.247262/-/DC1.

  • Received December 16, 2011.
  • Accepted May 16, 2012.
  • © 2012 American Heart Association, Inc.

References

  1. 1.↵
    1. Uemura M,
    2. Tatsumi K,
    3. Matsumoto M,
    4. Fujimoto M,
    5. Matsuyama T,
    6. Ishikawa M,
    7. Iwamoto TA,
    8. Mori T,
    9. Wanaka A,
    10. Fukui H,
    11. Fujimura Y
    . Localization of ADAMTS13 to the stellate cells of human liver. Blood. 2005;106:922–924.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Zheng X,
    2. Chung D,
    3. Takayama TK,
    4. Majerus EM,
    5. Sadler JE,
    6. Fujikawa K
    . Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem. 2001;276:41059–41063.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Tsai HM
    . Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood. 1996;87:4235–4244.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Zheng X,
    2. Majerus EM,
    3. Sadler JE
    . ADAMTS13 and TTP. Curr Opin Hematol. 2002;9:389–394.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Wagner DD,
    2. Marder VJ
    . Biosynthesis of von Willebrand protein by human endothelial cells: processing steps and their intracellular localization. J Cell Biol. 1984;99:2123–2130.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Goto S,
    2. Ikeda Y,
    3. Murata M,
    4. Handa M,
    5. Takahashi E,
    6. Yoshioka A,
    7. Fujimura Y,
    8. Fukuyama M,
    9. Handa S,
    10. Ogawa S
    . Epinephrine augments von Willebrand factor-dependent shear-induced platelet aggregation. Circulation. 1992;86:1859–1863.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Palmer DS,
    2. Aye MT,
    3. Ganz PR,
    4. Halpenny M,
    5. Hashemi S
    . Adenosine nucleotides and serotonin stimulate von Willebrand factor release from cultured human endothelial cells. Thromb Haemost. 1994;72:132–139.
    OpenUrlPubMed
  8. 8.↵
    1. Mayadas T,
    2. Wagner DD,
    3. Simpson PJ
    . von Willebrand factor biosynthesis and partitioning between constitutive and regulated pathways of secretion after thrombin stimulation. Blood. 1989;73:706–711.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Kaufmann JE,
    2. Oksche A,
    3. Wollheim CB,
    4. Günther G,
    5. Rosenthal W,
    6. Vischer UM
    . Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP. J Clin Invest. 2000;106:107–116.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Dong JF,
    2. Moake JL,
    3. Nolasco L,
    4. Bernardo A,
    5. Arceneaux W,
    6. Shrimpton CN,
    7. Schade AJ,
    8. McIntire LV,
    9. Fujikawa K,
    10. López JA
    . ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood. 2002;100:4033–4039.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Dong JF,
    2. Moake JL,
    3. Bernardo A,
    4. Fujikawa K,
    5. Ball C,
    6. Nolasco L,
    7. López JA,
    8. Cruz MA
    . ADAMTS-13 metalloprotease interacts with the endothelial cell-derived ultra-large von Willebrand factor. J Biol Chem. 2003;278:29633–29639.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Dong JF
    . Cleavage of ultra-large von Willebrand factor by ADAMTS-13 under flow conditions. J Thromb Haemost. 2005;3:1710–1716.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Tsai HM,
    2. Sussman II,
    3. Nagel RL
    . Shear stress enhances the proteolysis of von Willebrand factor in normal plasma. Blood. 1994;83:2171–2179.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Tsai HM,
    2. Lian EC
    . Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med. 1998;339:1585–1594.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Moake JL
    . Thrombotic microangiopathies. N Engl J Med. 2002;347:589–600.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Zheng X,
    2. Pallera AM,
    3. Goodnough LT,
    4. Sadler JE,
    5. Blinder MA
    . Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab. Ann Intern Med. 2003;138:105–108.
    OpenUrlPubMed
  17. 17.↵
    1. Chauhan AK,
    2. Kisucka J,
    3. Brill A,
    4. Walsh MT,
    5. Scheiflinger F,
    6. Wagner DD
    . ADAMTS13: a new link between thrombosis and inflammation. J Exp Med. 2008;205:2065–2074.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Reiter RA,
    2. Varadi K,
    3. Turecek PL,
    4. Jilma B,
    5. Knöbl P
    . Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation. Thromb Haemost. 2005;93:554–558.
    OpenUrlPubMed
  19. 19.↵
    1. Matsukawa M,
    2. Kaikita K,
    3. Soejima K,
    4. Fuchigami S,
    5. Nakamura Y,
    6. Honda T,
    7. Tsujita K,
    8. Nagayoshi Y,
    9. Kojima S,
    10. Shimomura H,
    11. Sugiyama S,
    12. Fujimoto K,
    13. Yoshimura M,
    14. Nakagaki T,
    15. Ogawa H
    . Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction. Am J Cardiol. 2007;100:758–763.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Bongers TN,
    2. de Maat MP,
    3. van Goor ML,
    4. Bhagwanbali V,
    5. van Vliet HH,
    6. Gómez García EB,
    7. Dippel DW,
    8. Leebeek FW
    . High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability. Stroke. 2006;37:2672–2677.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Tangirala RK,
    2. Tsukamoto K,
    3. Chun SH,
    4. Usher D,
    5. Puré E,
    6. Rader DJ
    . Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice. Circulation. 1999;100:1816–1822.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Kaikita K,
    2. Soejima K,
    3. Matsukawa M,
    4. Nakagaki T,
    5. Ogawa H
    . Reduced von Willebrand factor-cleaving protease (ADAMTS13) activity in acute myocardial infarction. J Thromb Haemost. 2006;4:2490–2493.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Crawley JT,
    2. Lane DA,
    3. Woodward M,
    4. Rumley A,
    5. Lowe GD
    . Evidence that high von Willebrand factor and low ADAMTS-13 levels independently increase the risk of a non-fatal heart attack. J Thromb Haemost. 2008;6:583–588.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Zhao BQ,
    2. Chauhan AK,
    3. Canault M,
    4. Patten IS,
    5. Yang JJ,
    6. Dockal M,
    7. Scheiflinger F,
    8. Wagner DD
    . von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke. Blood. 2009;114:3329–3334.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. De Maeyer B,
    2. De Meyer SF,
    3. Feys HB,
    4. Pareyn I,
    5. Vandeputte N,
    6. Deckmyn H,
    7. Vanhoorelbeke K
    . The distal carboxyterminal domains of murine ADAMTS13 influence proteolysis of platelet-decorated VWF strings in vivo. J Thromb Haemost. 2010;8:2305–2312.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Laje P,
    2. Shang D,
    3. Cao W,
    4. Niiya M,
    5. Endo M,
    6. Radu A,
    7. DeRogatis N,
    8. Scheiflinger F,
    9. Zoltick PW,
    10. Flake AW,
    11. Zheng XL
    . Correction of murine ADAMTS13 deficiency by hematopoietic progenitor cell-mediated gene therapy. Blood. 2009;113:2172–2180.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Niiya M,
    2. Endo M,
    3. Shang D,
    4. Zoltick PW,
    5. Muvarak NE,
    6. Cao W,
    7. Jin SY,
    8. Skipwith CG,
    9. Motto DG,
    10. Flake AW,
    11. Zheng XL
    . Correction of ADAMTS13 deficiency by in utero gene transfer of lentiviral vector encoding ADAMTS13 genes. Mol Ther. 2009;17:34–41.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Gandhi C,
    2. Khan MM,
    3. Lentz SR,
    4. Chauhan AK
    . ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice. Blood. 2012;119:2385–2391.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Chauhan AK,
    2. Motto DG,
    3. Lamb CB,
    4. Bergmeier W,
    5. Dockal M,
    6. Plaimauer B,
    7. Scheiflinger F,
    8. Ginsburg D,
    9. Wagner DD
    . Systemic antithrombotic effects of ADAMTS13. J Exp Med. 2006;203:767–776.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Massberg S,
    2. Brand K,
    3. Grüner S,
    4. Page S,
    5. Müller E,
    6. Müller I,
    7. Bergmeier W,
    8. Richter T,
    9. Lorenz M,
    10. Konrad I,
    11. Nieswandt B,
    12. Gawaz M
    . A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med. 2002;196:887–896.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Methia N,
    2. André P,
    3. Denis CV,
    4. Economopoulos M,
    5. Wagner DD
    . Localized reduction of atherosclerosis in von Willebrand factor-deficient mice. Blood. 2001;98:1424–1428.
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    1. Sperandio M,
    2. Smith ML,
    3. Forlow SB,
    4. Olson TS,
    5. Xia L,
    6. McEver RP,
    7. Ley K
    . P-selectin glycoprotein ligand-1 mediates L-selectin-dependent leukocyte rolling in venules. J Exp Med. 2003;197:1355–1363.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    1. Pendu R,
    2. Terraube V,
    3. Christophe OD,
    4. Gahmberg CG,
    5. de Groot PG,
    6. Lenting PJ,
    7. Denis CV
    . P-selectin glycoprotein ligand 1 and beta2-integrins cooperate in the adhesion of leukocytes to von Willebrand factor. Blood. 2006;108:3746–3752.
    OpenUrlAbstract/FREE Full Text
  34. 34.↵
    1. Lewinsohn DM,
    2. Bargatze RF,
    3. Butcher EC
    . Leukocyte-endothelial cell recognition: evidence of a common molecular mechanism shared by neutrophils, lymphocytes, and other leukocytes. J Immunol. 1987;138:4313–4321.
    OpenUrlAbstract
  35. 35.↵
    1. Tedder TF,
    2. Steeber DA,
    3. Pizcueta P
    . L-selectin-deficient mice have impaired leukocyte recruitment into inflammatory sites. J Exp Med. 1995;181:2259–2264.
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    1. Huo Y,
    2. Xia L
    . P-selectin glycoprotein ligand-1 plays a crucial role in the selective recruitment of leukocytes into the atherosclerotic arterial wall. Trends Cardiovasc Med. 2009;19:140–145.
    OpenUrlCrossRefPubMed
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Arteriosclerosis, Thrombosis, and Vascular Biology
August 2012, Volume 32, Issue 8
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • Sources of Funding
    • Disclosures
    • Footnotes
    • References
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics
  • eLetters

Article Tools

  • Print
  • Citation Tools
    Genetic Ablation of Adamts13 Gene Dramatically Accelerates the Formation of Early Atherosclerosis in a Murine Model
    Sheng-Yu Jin, Junichiro Tohyama, Robert C. Bauer, Na Nora Cao, Daniel J. Rader and X. Long Zheng
    Arteriosclerosis, Thrombosis, and Vascular Biology. 2012;32:1817-1823, originally published July 18, 2012
    https://doi.org/10.1161/ATVBAHA.112.247262

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  •  Download Powerpoint
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Arteriosclerosis, Thrombosis, and Vascular Biology.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Genetic Ablation of Adamts13 Gene Dramatically Accelerates the Formation of Early Atherosclerosis in a Murine Model
    (Your Name) has sent you a message from Arteriosclerosis, Thrombosis, and Vascular Biology
    (Your Name) thought you would like to see the Arteriosclerosis, Thrombosis, and Vascular Biology web site.
  • Share on Social Media
    Genetic Ablation of Adamts13 Gene Dramatically Accelerates the Formation of Early Atherosclerosis in a Murine Model
    Sheng-Yu Jin, Junichiro Tohyama, Robert C. Bauer, Na Nora Cao, Daniel J. Rader and X. Long Zheng
    Arteriosclerosis, Thrombosis, and Vascular Biology. 2012;32:1817-1823, originally published July 18, 2012
    https://doi.org/10.1161/ATVBAHA.112.247262
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects

  • Genetics
    • Genetically Altered and Transgenic Models
  • Intervention, Surgery, Transplantation
    • Treatment
  • Epidemiology, Lifestyle, and Prevention
    • Epidemiology
  • Basic, Translational, and Clinical Research
    • Platelets
    • Cell Signaling/Signal Transduction
    • Cell Biology/Structural Biology

Arteriosclerosis, Thrombosis, and Vascular Biology

  • About ATVB
  • Instructions for Authors
  • AHA CME
  • Meeting Abstracts
  • Permissions
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Contact the Editorial Office:
email: atvb@atvb.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured